ECM
AYTU icon

ETrade Capital Management’s AYTU BioPharma AYTU Stock Holding History

ETrade Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$87K Buy
364
+2
+0.6% +$514 ﹤0.01% 851
2020
Q2 		$103K Sell
362
-8
-2% -$2.42K ﹤0.01% 815
2020
Q1 		$111K Buy
+370
New +$71.4K ﹤0.01% 722

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ETrade Capital Management's AYTU Position: Q3 2020 in Review

ETrade Capital Management increased its AYTU BioPharma (AYTU) stake by 0.55% in Q3 2020, buying an estimated $514 and bringing the position to 364 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

ETrade Capital Management first reported a position in AYTU in Q1 2020 and has held it in 3 quarters since. The position peaked at $111K in Q1 2020. 57 funds tracked by Wall St. Rank hold AYTU as of Q3 2020.

  • ETrade Capital Management held 364 shares of AYTU BioPharma worth $87K as of Q3 2020.
  • ETrade Capital Management bought 2 AYTU BioPharma shares in Q3 2020, an estimated $514.
  • AYTU BioPharma made up ﹤0.01% of ETrade Capital Management's portfolio in Q3 2020, its #851 holding.
  • ETrade Capital Management first reported a position in AYTU BioPharma in Q1 2020 and has held it in 3 quarters since.
  • ETrade Capital Management's AYTU BioPharma position peaked at $111K in Q1 2020.
  • 57 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.